Equipulmin 25 micrograms/ml Syrup for Horses

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Buy It Now

Active ingredient:

Clenbuterol Hydrochloride

Available from:

CP Pharma Handelsgesellschaft mbH

ATC code:

QR03CC13

INN (International Name):

Clenbuterol Hydrochloride

Pharmaceutical form:

Syrup

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Horses

Therapeutic area:

Respiratory expectorant

Authorization status:

Authorized

Authorization date:

2012-12-18

Summary of Product characteristics

                                Revised: November 2021
AN: 00701/2021 and 00702/2021
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Equipulmin 25 micrograms/ml syrup for horses.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active substance
Clenbuterol hydrochloride
25 micrograms
(corresponding to 22 micrograms clenbuterol)
Preservatives:
Methyl parahydroxybenzoate (E218)
2.02 mg
Propyl parahydroxybenzoate
0.26 mg
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Syrup
Clear colourless syrup
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of respiratory disease in horses where it is considered that
airway obstruction
due to bronchospasm and/or accumulation of mucus is a contributing
factor, and
improved mucociliary clearance is desirable. To be used alone or as
adjuvant therapy.
4.3
CONTRAINDICATIONS
Do not use in cases of known hypersensitivity to the active substance
or any of the
excipients.
Do not use in horses with known cardiac disease.
For use during pregnancy or lactation see section 4.7.
Revised: November 2021
AN: 00701/2021 and 00702/2021
Page 2 of 6
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
In cases accompanied by bacterial infection the administration of
antimicrobial agents is
recommended.
In case of glaucoma the product must only be used after a careful
risk-benefit
assessment.
Special precautions should be taken in case of halothane anaesthesia,
since the heart
function can show increased sensitivity to catecholamines.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
This product contains clenbuterol hydrochloride, a beta-agonist.
Wear gloves to avoid skin contact. In case of accidental skin contact,
wash affected area
thoroughly. If irritation occurs/persists seek medical advice. Wash
hands thoroughly after
using the product.
Take care to avoid eye co
                                
                                Read the complete document